Reata Pharmaceuticals Inc

US BANCORP \DE\

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/10/2023

Shares

8,875

Value ($000)

905

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/10/2023	905	0.0%	8,875	6/30/2023
2023 Q1	5/9/2023	877	0.0%	9,646	3/31/2023
2022 Q4	2/13/2023	27	0.0%	699	12/31/2022
2022 Q3	10/27/2022	14	0.0%	547	9/30/2022
2022 Q2	8/1/2022	41	0.0%	1,339	6/30/2022
2022 Q1	5/11/2022	60	0.0%	1,824	3/31/2022
2021 Q4	2/11/2022	5	0.0%	177	12/31/2021
2021 Q3	11/10/2021	9	0.0%	94	9/30/2021
2021 Q2	8/5/2021	89	0.0%	627	6/30/2021
2021 Q1	4/28/2021	81	0.0%	808	3/31/2021
2020 Q4	2/4/2021	127	0.0%	1,028	12/31/2020
2020 Q3	11/10/2020	71	0.0%	728	9/30/2020
2020 Q2	8/7/2020	105	0.0%	679	6/30/2020
2020 Q1	5/13/2020	101	0.0%	705	3/31/2020
2019 Q4	2/4/2020	50	0.0%	245	12/31/2019